TerminatedNCT01733680
Amiloride Hydrochloride as an Effective Treatment for ADHD
Medication studyAges 18–55United States
Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
- Listed locations
- SyracuseSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- State University of New York - Upstate Medical University
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01733680
- Official title
Show the full official title
Amiloride Hydrochloride as an Effective Treatment for ADHD
Recruitment & locations
TerminatedSyracuse
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is State University of New York - Upstate Medical University, a university.
Does this study involve medication?
Yes. The study involves medication, including amiloride.
Who can participate?
This study is for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
